<DOC>
	<DOC>NCT01568086</DOC>
	<brief_summary>This is a phase Ib follow-up study to evaluate long-term safety and tolerability of immunization with AFFITOPE AD03 applied during AFFiRiS 005A.</brief_summary>
	<brief_title>Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005A</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Written informed consent signed and dated by the patient and the caregiver. Patients having participated in AFFiRiS 005A and received â‰¥1 vaccination with AFFITOPE AD03 Availability of a partner/caregiver knowing the patient and being able to accompany the patient to the visits and being available for the telephone phone calls Patients having received no vaccination with AFFITOPE AD03 History of questionable compliance to visit schedule; patients not expected to complete the clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>